SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
10-Apr-19 4:36 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 08-Apr-19 | Grant | 56,250 | -- | -- | 15% 375.53K to 431.78K | |
21-Mar-19 4:37 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 20-Mar-19 | Market Sale | 6,319 | $7.99 | $50,488.80 | (2%) 381.85K to 375.53K | (3%) |
08-Nov-18 6:04 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 07-Nov-18 | Market Purchase | 3,850 | $12.98 | $49,956.40 | 1% 378.0K to 381.85K | (37%) |
22-Mar-18 5:58 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 21-Mar-18 | Market Sale | 4,541 | $25.75 | $116,931.00 | (< 1%) 542.54K to 538.0K | 68% |
09-Mar-18 8:54 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 06-Mar-18 | Grant | 20,625 | -- | -- | 4% 521.92K to 542.54K | |
22-Mar-17 5:06 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 21-Mar-17 | Market Sale | 2,807 | $17.03 | $47,803.20 | (< 1%) 524.73K to 521.92K | 52% |
23-Feb-17 5:38 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 21-Feb-17 | Grant | 23,125 | -- | -- | 5% 501.6K to 524.73K | |
07-Oct-16 5:07 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 05-Oct-16 | Disposition (other) | 117,450 | -- | -- | (14%) 814.45K to 697.0K | |
07-Oct-16 5:07 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 05-Oct-16 | Disposition (other) | 195,400 | -- | -- | (28%) 697.0K to 501.6K | |
16-Jun-16 6:03 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 15-Jun-16 | Option Exercise | 204,900 | $1.88 | $384,188.00 | 34% 609.55K to 814.45K | |
08-Mar-16 6:00 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 04-Mar-16 | Grant | 28,750 | $13.66 | $392,725.00 | 5% 580.8K to 609.55K | (45%) |
14-May-15 7:48 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 14-May-15 | Option Exercise | 100 | $1.88 | $187.50 | < 1% 594.33K to 594.43K | |
14-May-15 7:48 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 14-May-15 | Market Option Sale | 100 | $18.00 | $1,800.00 | (< 1%) 594.43K to 594.33K | 59% |
14-May-15 7:48 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 14-May-15 | Market Option Sale | 200 | $18.00 | $3,600.00 | (< 1%) 594.33K to 594.13K | 59% |
14-May-15 7:48 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 13-May-15 | Option Exercise | 10,028 | $1.88 | $18,802.50 | 2% 584.43K to 594.46K | |
14-May-15 7:48 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 13-May-15 | Market Option Sale | 28 | $18.00 | $504.00 | (< 1%) 594.46K to 594.43K | 59% |
14-May-15 7:48 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 13-May-15 | Market Option Sale | 100 | $18.00 | $1,800.00 | (< 1%) 594.43K to 594.33K | 59% |
14-May-15 7:48 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 12-May-15 | Option Exercise | 500 | $1.88 | $937.50 | < 1% 586.23K to 586.73K | |
14-May-15 7:48 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 12-May-15 | Market Option Sale | 500 | $18.01 | $9,003.00 | (< 1%) 586.73K to 586.23K | 59% |
14-May-15 7:48 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 12-May-15 | Market Option Sale | 1,800 | $18.00 | $32,400.00 | (< 1%) 586.23K to 584.43K | 59% |
27-Apr-15 5:14 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 23-Apr-15 | Option Exercise | 900 | $1.88 | $1,687.50 | < 1% 588.63K to 589.53K | |
27-Apr-15 5:14 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 23-Apr-15 | Market Option Sale | 900 | $18.00 | $16,200.00 | (< 1%) 589.53K to 588.63K | 59% |
27-Apr-15 5:14 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 23-Apr-15 | Market Sale | 2,400 | $18.00 | $43,212.00 | (< 1%) 588.63K to 586.23K | 59% |
22-Apr-15 7:00 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 21-Apr-15 | Option Exercise | 962 | $1.88 | $1,803.75 | < 1% 590.44K to 591.4K | |
22-Apr-15 7:00 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 21-Apr-15 | Market Sale | 962 | $18.01 | $17,322.20 | (< 1%) 591.4K to 590.44K | 59% |
22-Apr-15 7:00 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 21-Apr-15 | Market Sale | 1,811 | $18.00 | $32,602.30 | (< 1%) 590.44K to 588.63K | 59% |
22-Apr-15 7:00 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 20-Apr-15 | Option Exercise | 2,610 | $1.88 | $4,893.75 | < 1% 595.64K to 598.25K | |
22-Apr-15 7:00 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 20-Apr-15 | Market Option Sale | 2,610 | $18.00 | $46,980.50 | (< 1%) 598.25K to 595.64K | 59% |
22-Apr-15 7:00 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 20-Apr-15 | Market Option Sale | 962 | $18.00 | $17,316.20 | (< 1%) 595.64K to 594.68K | 59% |
22-Apr-15 7:00 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 20-Apr-15 | Market Sale | 4,238 | $18.00 | $76,284.90 | (< 1%) 594.68K to 590.44K | 59% |
14-Apr-15 7:32 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 14-Apr-15 | Option Exercise | 80 | $1.88 | $150.00 | < 1% 585.74K to 585.82K | |
14-Apr-15 7:32 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 14-Apr-15 | Private Sale | 10,000 | $1.88 | $18,750.00 | 2% 585.82K to 595.82K | |
14-Apr-15 7:32 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 14-Apr-15 | Market Sale | 80 | $18.00 | $1,440.00 | (< 1%) 595.82K to 595.74K | 59% |
14-Apr-15 7:32 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 14-Apr-15 | Market Sale | 100 | $18.00 | $1,800.00 | (< 1%) 595.74K to 595.64K | 59% |
14-Apr-15 7:32 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 10-Apr-15 | Option Exercise | 1,000 | $1.88 | $1,875.00 | < 1% 589.32K to 590.32K | |
14-Apr-15 7:32 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 10-Apr-15 | Market Option Sale | 1,000 | $18.18 | $18,180.00 | (< 1%) 590.32K to 589.32K | 59% |
14-Apr-15 7:32 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 10-Apr-15 | Market Option Sale | 80 | $18.29 | $1,462.94 | (< 1%) 589.32K to 589.24K | 59% |
14-Apr-15 7:32 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 10-Apr-15 | Market Sale | 3,497 | $18.29 | $63,948.80 | (< 1%) 589.24K to 585.74K | 59% |
24-Mar-15 5:07 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 20-Mar-15 | Option Exercise | 100 | $1.88 | $187.50 | < 1% 589.52K to 589.62K | |
24-Mar-15 5:07 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 20-Mar-15 | Market Option Sale | 100 | $18.00 | $1,800.00 | (< 1%) 589.62K to 589.52K | 59% |
24-Mar-15 5:07 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 20-Mar-15 | Market Sale | 200 | $18.00 | $3,600.00 | (< 1%) 589.52K to 589.32K | 59% |
19-Mar-15 7:53 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 19-Mar-15 | Option Exercise | 12,320 | $1.88 | $23,100.00 | 2% 581.67K to 593.99K | |
19-Mar-15 7:53 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 19-Mar-15 | Market Option Sale | 2,320 | $18.00 | $41,760.00 | (< 1%) 593.99K to 591.67K | 59% |
19-Mar-15 7:53 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 19-Mar-15 | Market Option Sale | 580 | $18.00 | $10,440.00 | (< 1%) 591.67K to 591.09K | 59% |
19-Mar-15 7:53 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 19-Mar-15 | Market Sale | 1,568 | $18.00 | $28,224.00 | (< 1%) 591.09K to 589.52K | 59% |
19-Mar-15 7:53 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 18-Mar-15 | Option Exercise | 4,600 | $1.88 | $8,625.00 | < 1% 591.09K to 595.69K | |
19-Mar-15 7:53 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 18-Mar-15 | Market Option Sale | 1,900 | $18.00 | $34,201.30 | (< 1%) 595.69K to 593.79K | 59% |
19-Mar-15 7:53 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 18-Mar-15 | Market Sale | 2,700 | $18.00 | $48,601.90 | (< 1%) 593.79K to 591.09K | 59% |
19-Mar-15 7:53 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 18-Mar-15 | Market Option Sale | 9,420 | $18.00 | $169,602.00 | (2%) 591.09K to 581.67K | 59% |
19-Mar-15 7:53 PM View: | Adamas Pharmaceuticals Inc (ADMS) | 17-Mar-15 | Option Exercise | 1,900 | $1.88 | $3,562.50 | < 1% 593.79K to 595.69K |